Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 AUIC--the universal parameter within the constraint of a reasonable dosing interval.

× No keyword cloud information.

8 in total

Review 1. Achieving an optimal outcome in the treatment of infections. The role of clinical pharmacokinetics and pharmacodynamics of antimicrobials.

Authors: R C Li; M Zhu; J J Schentag
Journal: Clin Pharmacokinet Date: 1999-07 Impact factor: 6.447

2. Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy.

Authors: J K Thomas; A Forrest; S M Bhavnani; J M Hyatt; A Cheng; C H Ballow; J J Schentag
Journal: Antimicrob Agents Chemother Date: 1998-03 Impact factor: 5.191

3. Pharmacokinetic/pharmacodynamic (PK/PD) indices of antibiotics predicted by a semimechanistic PKPD model: a step toward model-based dose optimization.

Authors: Elisabet I Nielsen; Otto Cars; Lena E Friberg
Journal: Antimicrob Agents Chemother Date: 2011-08-01 Impact factor: 5.191

Review 4. Basis of anti-infective therapy: pharmacokinetic-pharmacodynamic criteria and methodology for dual dosage individualisation.

Authors: A Sánchez-Navarro; M M Sánchez Recio
Journal: Clin Pharmacokinet Date: 1999-10 Impact factor: 6.447

5. Assessing antibacterial pharmacoeconomics in the intensive care unit.

Authors: M C Birmingham; J M Hassett; J J Schentag; J A Paladino
Journal: Pharmacoeconomics Date: 1997-12 Impact factor: 4.981

Review 6. Clinical use of ceftriaxone: a pharmacokinetic-pharmacodynamic perspective on the impact of minimum inhibitory concentration and serum protein binding.

Authors: T R Perry; J J Schentag
Journal: Clin Pharmacokinet Date: 2001 Impact factor: 6.447

Review 7. Selecting antibacterials for outpatient parenteral antimicrobial therapy : pharmacokinetic-pharmacodynamic considerations.

Authors: Richard S Slavik; Peter J Jewesson
Journal: Clin Pharmacokinet Date: 2003 Impact factor: 6.447

Review 8. Moxifloxacin in the management of exacerbations of chronic bronchitis and COPD.

Authors: Marc Miravitlles
Journal: Int J Chron Obstruct Pulmon Dis Date: 2007

8 in total